Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands | Total | Common Stock | Paid-in Capital | Retained Earnings | Treasury Stock |
Beginning Balance (in shares) at Sep. 30, 2019 | | 10,861,950 | | | |
Beginning Balance at Sep. 30, 2019 | $ 29,447 | $ 109 | $ (4,377) | $ 34,715 | $ (1,000) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (1,718) | | | (1,718) | |
Share based compensation expense | 14 | | 14 | | |
Ending Balance (in shares) at Dec. 31, 2019 | | 10,861,950 | | | |
Ending Balance at Dec. 31, 2019 | 27,743 | $ 109 | (4,363) | 32,997 | (1,000) |
Beginning Balance (in shares) at Sep. 30, 2019 | | 10,861,950 | | | |
Beginning Balance at Sep. 30, 2019 | 29,447 | $ 109 | (4,377) | 34,715 | (1,000) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (16,379) | | | | |
Ending Balance (in shares) at Mar. 31, 2020 | | 10,971,950 | | | |
Ending Balance at Mar. 31, 2020 | 13,724 | $ 109 | (3,722) | 18,336 | (1,000) |
Beginning Balance (in shares) at Dec. 31, 2019 | | 10,861,950 | | | |
Beginning Balance at Dec. 31, 2019 | 27,743 | $ 109 | (4,363) | 32,997 | (1,000) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (14,661) | | | (14,661) | |
Restricted stock issuance | 377 | | 377 | | |
Stock option exercise (in shares) | | 110,000 | | | |
Stock option exercise | 173 | $ 1 | 172 | | |
Share based compensation expense | 92 | | 92 | | |
Ending Balance (in shares) at Mar. 31, 2020 | | 10,971,950 | | | |
Ending Balance at Mar. 31, 2020 | 13,724 | $ 109 | (3,722) | 18,336 | (1,000) |
Beginning Balance (in shares) at Sep. 30, 2020 | | 11,822,009 | | | |
Beginning Balance at Sep. 30, 2020 | 14,933 | $ 118 | (2,567) | 17,382 | 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (1,953) | | | (1,953) | |
Issuance of common shares (in shares) | | 238,194 | | | |
Issuance of common shares | 879 | $ 3 | 876 | | |
Restricted stock issuance (in shares) | | 306,390 | | | |
Restricted stock issuance | 0 | $ 3 | (3) | | |
Share based compensation expense | 315 | | 315 | | |
Ending Balance (in shares) at Dec. 31, 2020 | | 12,366,593 | | | |
Ending Balance at Dec. 31, 2020 | 14,174 | $ 124 | (1,379) | 15,429 | 0 |
Beginning Balance (in shares) at Sep. 30, 2020 | | 11,822,009 | | | |
Beginning Balance at Sep. 30, 2020 | 14,933 | $ 118 | (2,567) | 17,382 | 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | $ (5,017) | | | | |
Stock option exercise (in shares) | 49,000 | | | | |
Ending Balance (in shares) at Mar. 31, 2021 | | 12,413,372 | | | |
Ending Balance at Mar. 31, 2021 | $ 11,465 | $ 124 | (1,023) | | 0 |
Beginning Balance (in shares) at Dec. 31, 2020 | | 12,366,593 | | | |
Beginning Balance at Dec. 31, 2020 | 14,174 | $ 124 | (1,379) | 15,429 | 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | |
Net loss | (3,064) | | | $ (3,064) | |
Issuance of common shares (in shares) | | 7,779 | | | |
Issuance of common shares | 21 | | 21 | | |
Restricted stock issuance (in shares) | | (10,000) | | | |
Restricted stock issuance | (1) | $ (1) | | | |
Stock option exercise (in shares) | | 49,000 | | | |
Stock option exercise | 89 | | 89 | | |
Share based compensation expense | 246 | | 246 | | |
Ending Balance (in shares) at Mar. 31, 2021 | | 12,413,372 | | | |
Ending Balance at Mar. 31, 2021 | $ 11,465 | $ 124 | $ (1,023) | | $ 0 |